EC therapy activates the PERK–eIF2α–ATF4 signaling pathway to increase ER stress, thereby promoting ferroptosis in lung cancer cells and inhibiting the occurrence and development of lung cancer. This evidence concerns the gene EIF2AK3 and lung carcinoma.